MDXG MiMedx Group, Inc
$3.84▼ -3.40%
Healthcare
Other
Volume 1.19M
Avg Volume (10D) 2.08M
Key Metrics & Fundamentals
Market Cap
$559.62M
P/E Ratio
99.3
Div Yield
0.00%
52W Range
3.03 - 7.97
% vs 50 MA
-11.68%
% vs 200 MA
-7.26%
RSI-14
35.4
MACD Histogram
-0.0600
Beta (1Y vs SPY)
0.81
Free Cash Flow
-$1.14M
Gross Rev
$62.28M
Gross Profit
$49.70M
EBITDA
-$9.39M
COGS
$12.58M
Operating Exp
$61.40M
Operating Income
-$11.70M
EBIT
-$11.70M
Pretax Income
-$11.06M
Net Income
-$8.68M
EPS (Diluted)
-0.06
Price & Volume History
Loading chart…
Recent News
MiMedx Group, Inc. Q3 2026 Earnings Call Summary
Moby · Oct 29, 2026 8:30 AM ET
MiMedx Group Inc (MDXG) (Q3 2026) Earnings Call Highlights: Revenue Jumps 36% as Neurosurgery ...
GuruFocus.com · Oct 29, 2026 1:09 AM ET
MiMedx (MDXG) Q3 2026 Earnings Call Transcript
Motley Fool · Oct 29, 2026 12:43 AM ET
What MiMedx Group (MDXG) Said on Its Q3 Earnings Call
MarketBeat · Oct 28, 2026 11:04 PM ET
MiMedx: Q3 Earnings Snapshot
Associated Press · Oct 28, 2026 4:56 PM ET
MIMEDX Announces Third Quarter 2026 Operating & Financial Results
GlobeNewswire · Oct 28, 2026 4:03 PM ET
MIMEDX Announces $25 Million Patent License Agreement
GlobeNewswire · Oct 28, 2026 4:01 PM ET
MiMedx-Sanara Merger Faces Fresh Regulatory Obstacle – SMTI Stock Falls Below This Key Support Level For The First Time In 4 Months
Stocktwits · Oct 16, 2026 1:00 PM ET
MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026
GlobeNewswire · Oct 14, 2026 4:01 PM ET
MiMedx Says it Received Favorable Court Ruling in Axiofill Classification Matter
MT Newswires · Sep 23, 2026 4:53 PM ET
Financial Overview - Income Statement
Quarterly
Sep 2026
See MDXG's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.